NYSE:ARDT - US03980N1072 - Common Stock
The current stock price of ARDT is 12.69 USD. In the past month the price increased by 24.17%. In the past year, price decreased by -36.01%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 16.87 | 94.52B | ||
THC | TENET HEALTHCARE CORP | 12.5 | 16.29B | ||
EHC | ENCOMPASS HEALTH CORP | 24.5 | 12.26B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 9.65 | 11.56B | ||
ENSG | ENSIGN GROUP INC/THE | 28.68 | 9.91B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 19.35 | 3.05B | ||
SGRY | SURGERY PARTNERS INC | 27.01 | 2.91B | ||
ACHC | ACADIA HEALTHCARE CO INC | 8.26 | 2.12B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.83B | ||
PACS | PACS GROUP INC | 15.32 | 1.81B | ||
NHC | NATIONAL HEALTHCARE CORP | 16.91 | 1.76B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 12.27 | 1.61B |
Ardent Health, Inc. engages in the provision of healthcare and related services. The company is headquartered in Brentwood, Tennessee and currently employs 19,200 full-time employees. The company went IPO on 2024-07-18. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. The company provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
ARDENT HEALTH INC
340 Seven Springs Way, Suite 100
Brentwood TENNESSEE US
Employees: 19200
Phone: 16152963000
The current stock price of ARDT is 12.69 USD. The price increased by 1.28% in the last trading session.
The exchange symbol of ARDENT HEALTH INC is ARDT and it is listed on the New York Stock Exchange, Inc. exchange.
ARDT stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed ARDT and the average price target is 20.09 USD. This implies a price increase of 58.35% is expected in the next year compared to the current price of 12.69. Check the ARDENT HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARDENT HEALTH INC (ARDT) has a market capitalization of 1.82B USD. This makes ARDT a Small Cap stock.
ARDENT HEALTH INC (ARDT) currently has 19200 employees.
ARDENT HEALTH INC (ARDT) has a support level at 12.68 and a resistance level at 12.99. Check the full technical report for a detailed analysis of ARDT support and resistance levels.
The Revenue of ARDENT HEALTH INC (ARDT) is expected to grow by 8.62% in the next year. Check the estimates tab for more information on the ARDT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ARDT does not pay a dividend.
The PE ratio for ARDENT HEALTH INC (ARDT) is 7.09. This is based on the reported non-GAAP earnings per share of 1.79 and the current share price of 12.69 USD. Check the full fundamental report for a full analysis of the valuation metrics for ARDT.
The outstanding short interest for ARDENT HEALTH INC (ARDT) is 1.88% of its float. Check the ownership tab for more information on the ARDT short interest.
ChartMill assigns a technical rating of 2 / 10 to ARDT. When comparing the yearly performance of all stocks, ARDT is a bad performer in the overall market: 91.33% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to ARDT. ARDT has an average financial health and profitability rating.
Over the last trailing twelve months ARDT reported a non-GAAP Earnings per Share(EPS) of 1.79. The EPS increased by 314.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.11% | ||
ROA | 5.07% | ||
ROE | 20.31% | ||
Debt/Equity | 0.87 |
17 analysts have analysed ARDT and the average price target is 20.09 USD. This implies a price increase of 58.35% is expected in the next year compared to the current price of 12.69.
For the next year, analysts expect an EPS growth of 52.25% and a revenue growth 8.62% for ARDT